---
title: "Acrivon Therapeutics, Inc. (ACRV.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/ACRV.US.md"
symbol: "ACRV.US"
name: "Acrivon Therapeutics, Inc."
industry: "Biotechnology"
---

# Acrivon Therapeutics, Inc. (ACRV.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [acrivon.com](https://acrivon.com) |

## Company Profile

Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precisio...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.61 | 153/603 | - | - | - |
| PB | 0.39 | 26/603 | 0.57 | 0.38 | 0.25 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-12T05:00:00.000Z

Total Analysts: **9**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 5 | 56% |
| Overweight | 3 | 33% |
| Hold | 1 | 11% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.59 |
| Highest Target | 19.00 |
| Lowest Target | 7.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/ACRV.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/ACRV.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/ACRV.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.